$BIXT Income Statement | Understand Stock

$BIXT

$0.02 +$0.00 (3.86%) Close

Financial Statements

In USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating expenses:
Research and development
General and administrative
General and administrative related party
Compensation expense
General and administrative affiliates
Total operating expenses
Loss from operations
Interest expense
Other expenses:
Loss of issuance
Change in FV of Derivative
Interest expense
Interest expense affiliate
Amortization of Intellectual Property
Debt forgiveness
Debt discount amortization
Total other expenses
Net loss before provision for income taxes

Net loss before provision for income taxes
Net loss
Net loss attributable to the non-controlling interest
Loss per common share, basic and diluted
Weighted average number of common shares outstanding, basic and diluted
NET LOSS ATTRIBUTABLE TO BIOXYTRAN
Loss per common share, basic
Loss per common share, diluted
Weighted average number of common shares outstanding, basic
Weighted average number of common shares outstanding, diluted

Comments